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ABSTRACT
With the recent creation of Metal Organic Biohybrids (MOBs) from the DeCoster
lab group at Louisiana Tech University, a new class of nano and micro particles needs to
be investigated. The amalgamation of metals such as copper and an amino acid have
already shown promise for biomedical applications such as delayed drug delivery or time
delayed anti-microbial effects1. In this study the effects of cobalt, copper, and zinc-based
MOBs have been compared against silicon dioxide nanoparticles, a negative control, and
copper oxide nanoparticles, a positive control, in order to observe their effects on
cancerous glioma cells and healthy astrocyte cells. The cellular health was examined in
terms of cell metabolism, calcium response intensity and nuclear morphology via MTT
assay, DAPI staining and calcium imaging.
The study showed that all MOBs tested had desired negative effects on both the
astrocyte and glioma cell lines. Of exception were CuHARs which were able to
successfully decrease the astrocyte metabolism by 21% and the glioma was more harshly
affected at 29%. Calcium imaging data of glioma also showed an initial suppression
followed by agitation concluded by suppression when compared to control cells. When
CuHARs were compared to CuNPs by concentration of copper mass present in the total
dose of the material. the metabolism was 89 ± 0% CuNPs and 94 ± 0% CuHARs at
24Hrs. In summary, all MOBs tested showed promise and with alterations to dosages,
amounts, and loadings they may be a key to a new cancer treatment method.
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CHAPTER 1
INTRODUCTION

1.1 Nanoparticles and Metal Organic Biohybrids (MOBs)
In the field of nanomedicine, we often look to the human body for inspiration.
There’s often a pre-existing solution to a problem, and our duty is to study and replicate
those functions with artificial means to improve health and quality of life. One such
method of replicating these mechanisms is doped nanoparticles. Doped nanoparticles are
small, easily manipulable, and full of potential2. In the medical field, researchers have
experimented with these particles by: loading them with drugs, tracking their movement,
and guiding them to a final resting spot in the body. Their industrial applications range
from beauty products, industrial chemistry, and oil drilling3, to medicine. With
dimensions ranging of 100nm in diameter and smaller, their reactive surface area is
higher per mass and volume than a more macro counter part4, and is more susceptible to
chemical, magnetic manipulation, and sonic influences. The addition of a simple
nanoparticle such as raw copper or silver nanoparticles5, while retaining their
antimicrobial properties, can be so toxic to normal healthy tissue it is a challenge to
utilize them6. However, with the advent of Metal Organic Biohybrids (MOBs)7, a particle
created by the synthesis of an amino acid such as cysteine and a metal (copper, cobalt or
zinc for example), one can reduce the toxic effects and possibly provide a new method of
treatment for cancer1.

1

2
Copper nanoparticles (CuNPs) are copper only materials with a size of 1-100nm in
diameter. They can be made from a vast array of copper-based compounds, either from
lab reagents or biologically8. Due to the range of manufacturing methods and copper’s
natural abundance, they are cheap and relatively easy to make. CuNPs are used in
chemistry as a catalyst, preferred for their high surface area, and also have uses in other
fields such as the production of dyes and biocides. This last entry is due to their toxic
nature, and the toxic effects are dependent upon concentration9. In this study, CuNPs
were selected as a positive control for their known toxic effects in cell culture.
Copper High Aspect Ratio Structures (CuHARS) are a unique class of MOB as
standard MOB synthesis produces a roughly spherical product. CuHARS’ synthesis,
however, form long rod-like structures ranging from nanometers to a few hundred
microns in length and maxes at 10 microns in width; hence high aspect ratio. These
materials have already been successfully incorporated in cellulose bandages for
controlled degradation, wound healing, and are desired for their antimicrobial properties1.
CuHARs are synthesized in accordance to the directions in Appendix F and made from
CuSO4 obtained from Sigma-Aldrich (St. Louis, MO, USA). Although, CuNPs can be
substituted. In this study, CuHARs will be directly compared to the non-biological
CuNPs. It is hypothesized that by mass of copper present, CuHARs compared to CuNPs
would have a less toxic effect due to the reduced surface area slowing down the reaction
kinetics and prolonging the exposure of copper-based dosing over a longer period of time
at a lower dose. This may be desirable for medical applications.
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Cobalt MOBs (Co MOBs) are made by combining cobalt (II or III) oxide nano
powder with the amino acid cysteine at 37°C, both obtained from Sigma-Aldrich (St.
Louis, MO, USA), in accordance with the standard synthesis prescribed in Appendix F.
These products are novel and were created in our lab in July of 2021. Cobalt
nanoparticles, however, have been used in medical tracking in MRI contrast solution10,
and in an array of magnetic based biosensors11. They also have been used for studying
applications in cytotoxicity which show that they increase the presence of apoptotic
reactions in human embryonic kidney cells, and have possible applications in cancer
treatments12. It is hypothesized that cobalt MOBs will have a less toxic effect than
CuNPs due to the reduced surface area of the particle. However, they will have a more
toxic effect than the CuHARs due to a higher charge of free cobalt ions compared to free
copper ions once the MOB breaks down.
Zinc MOBs are made by combining ZnSO4*7H2O, obtained from Sigma-Aldrich (St.
Louis, MO, USA), with the amino acid cystine in accordance with the standard synthesis
prescribed in Appendix F. Zinc oxide nanoparticles have been studied for their role as a
cytotoxic agent12. It is hypothesized that there may be similar damage to the cells from
Zinc MOBs compared to the CuHARs due to a similar free ion charge (+2).
Silicon dioxide nanoparticles were selected in this study for their known nonbiodegradable, inert qualities in cell culture. They are studied for their porous nature
which makes them natural drug delivery devices13,14. In this study, they will serve as a
control for the presence of a chemically unreactive and non-biodegradable object; simply
taking up space. I hypothesize that due to silicon dioxide’s inert nature and zero charge,
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the particles will have no discernable effect on the cell’s health aside from a slight
slowing in development due to the particles occupying free space.
In summary, each of these nanoparticles possess a possible solution to a vast array of
issues. In this study, we are primarily looking at their effects on brain cells and their
possible uses to selectively treat or detect glioma cells without severe consequences to
the normal astrocyte cells15. The effects of each nanoparticle are caused by the metal
substrates emitted as the materials degrade. They may share a common size and set of
features, but their influences on cells will entirely be determined on their base metal and
their organic constituent. It is hypothesized that a metal-based nanoparticle will have the
most detrimental effects on a cell culture, followed by more mild effects from an MOB,
and lastly a nearly unaffected culture with silicon dioxide particles.
1.2 Research Objectives
Throughout this work, there will be a few key points of interest for observation,
listed below as research objectives. These will not be the only observations made, but
serve as the driving questions to guided this work.

1. Study the effects of novel nanomaterials interacting with astrocyte and glioma
cells. This research will primarily focus on copper nanoparticles (CuNPs), silicon
dioxide nanoparticles (SiO2), and copper-based MOBs (often known as
CuHARS), zinc (Zn MOBs), and cobalt (Co MOBs) on healthy and diseased
brain cells. Their effects will be characterized via cellular metabolism, calcium
response to stimulus, and cell morphology.
2. Compare the toxicity effects of nano particles to biological MOBs.
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2.A) Compare the toxicity effects of materials on glioma and astrocytes via MTT
assay.
2.B) Compare the toxicity effects of materials on glioma and astrocytes via
nuclear DAPI staining and computer aided examination of nuclear morphology.
3. Examine the acute effect of materials on the glioma cell’s ability to respond to
environmental stimulus utilizing calcium imaging.

CHAPTER 2
METHODOLOGY

2.1 Copper Nanoparticles
Copper nanoparticles are an industry standard for cytotoxic effects and are
commonly implemented for antimicrobial properties16,17,18. In this study, the CuNPs were
obtained from an unrefrigerated stock solution of 2.0mg/ml in sterile water. The
nanoparticles themselves were obtained from Sigma-Aldrich (St. Louis, MO, USA). The
nanoparticles are a brown-black ink color in solution and will settle heavily, so sonication
is needed before aliquoting, as shown below in Fig. 2-1-1. A solution of nanoparticles for
cell culture was then made from this stock solution in the desired media for experiments.

Figure 2-1-1: Vortexed CuNPs stock solution 2mg/ml.

26
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2.2 Copper MOBs (CuHARS)
CuHARs wer e synthesized by the standard procedure in Appendix F. Once the
particles are synthesized, they must be spun down in a centrifuge at 2500 RFC, 10°C, in
20-minute intervals in a 15ml centrifuge tube. Once a pellet of product is formed at the
bottom, all but the last 1.0ml of supernatant is removed and discarded. The last 1.0ml is
then mixed with the pellet using a pipette-aid, and is then dried on a glass slide at 37°C.
This was done to prevent decomposition. The dried product is then scraped using a razor
blade and weighed, then either stored dry or at 1mg/ml in sterile water and refrigerated.
The dried product should be light baby blue in color7. In solution, CuHARs will settle
heavily, so sonication is needed before aliquoting. A solution of nanoparticles was then
made from this in the desired media for cell culture.
2.2.1

Proposed CuHARS Structures

The following figures below are generated models of reagents and possible products
of CuHARs synthesis. These models below were generated using the website
MoleView.19 The model on the next page, Fig. 2-2-1 and subsequent models have red as
oxygen and terracotta as copper . These copper oxides represent the CuNPs used in this
study.
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Figure 2-2-1: Copper (I) oxide (left) and copper (II) oxide (right), a nanoparticle starting
regent used in synthesis of CuHARs (product).
Next displayed Fig. 2-2-2, is the Cystine20,21 molecule, not to be confused with
Cysteine, the former being an oxidized dimer of the latter’s amino acid self-joined at the
yellow sulfur.

Figure 2-2-2: Cystine starting reagent used for synthesis.
First to be introduced, Fig 2-2-3, for possible products is this molecule where
copper has super imposed itself in between the two amino acids22.
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Figure 2-2-3: Cystine central copper superimposition of cystine, possible product
structure. Note the linear aspect.
Next is a cystine molecule in Figure 2-2-4 which shows a copper capped cystine23
possibly explain CuHARs limited width.

Figure 2-2-4: Cystine capped copper structure of cystine, possible product structure.
Lastly is the chain of cysteine amino acids capped with copper ions24,25, Figure 22-5. This structure may explain CuHARs’ length.
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Figure 2-2-5: Cystine chain with copper R groups possible product structure.
2.3 Zinc MOBs
Zn MOBs were synthesized by the standard procedure in Appendix F. Once the
particles are synthesized, they must be spun down in a centrifuge at 2500 RFC, 10°C in
20-minute intervals in a 15ml centrifuge tube. Once a pellet of product is formed at the
bottom, all but the last 1.0ml of supernatant is removed and discarded. The last 1.0ml is
then mixed with the pellet using a pipette-aid, and is then dried on a glass slide at 37°C.
The dried product is then scraped using a razor blade and weighed, then either stored dry
or at 1mg/ml in sterile water and refrigerated. In practice this method (7 ml synthesis,
Appendix F) yields an average of 0.093 mg of product per synthesis, and if scaled up to
triple the volume (21 ml flask synthesis), the yield is 0.07mg per 7ml synthesis. This
shows that while loss occurs due to less favorable environments, scaling the synthesis is
possible26, 27. Zinc MOBs were stored in a 1mg/ml solution with sterile water and
refrigerated. Zinc MOBs should have a white color in dried product, and in solution will
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settle lightly, so vortexing/titration is needed before aliquoting. A solution of
nanoparticles, as below in Figure 2-3-1, was then made from this in the desired media for
experiments.

Figure 2-3-1: Freshly collected zinc MOB synthesis product in a 15ml tube.
Approximate mass of 0.28mg left and 0.21mg right.
2.4 Cobalt MOBs
Co MOBs were synthesized by the standard procedure in Appendix F. Once the
particles are synthesized, they must be spun down in a centrifuge at 2500 RFC, 10°C in
20-minute intervals in a 15ml centrifuge tube. Once a pellet of product is formed at the
bottom, all but the last 1.0ml of supernatant is removed and discarded. The last 1.0ml is
then mixed with the pellet using a pipette-aid, and is then dried on a glass slide at 37°C.
The dried product is then scraped using a razor blade and weighed, then either stored dry
or at 1mg/ml in sterile water and refrigerated. In practice according to Appendix F, 0.6
mg of product was achieved from a 41ml of synthesis across six batches of 7ml synthesis,
yielding 0.08 mg of product per standard synthesis. In solution, as shown on the next
page in Figure 2-4-1, the cobalt should have a distinct pale-yellow color28 and will settle
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mildly, so vortexing is needed before aliquoting. A solution of nanoparticles was then
made from this in the desired media for cell culture.

Figure 2-4-1: Successful synthesis product liquid of Co MOBs in suspension.
2.5 Silicon Nanoparticles
Silicon dioxide nanoparticles (5-15nm)14 were obtained from company SigmaAldrich (St. Louis, MO, USA), and then placed in a 2mg/ml solution with sterile water
and refrigerated. In solution, the silicon nanoparticles should have a pale white color13
and will settle heavily, so vortexing is needed before aliquoting. A solution of
nanoparticles, shown on the next page in Figure 2-5-1, was then made from this in the
desired media for cell culture.
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Figure 2-5-1: Silicon dioxide nanoparticles in suspension.
2.6 Cell Culture and Addition of Materials
In cell culture, 24 well cell culture plates, as shown in Figure 2-6-1, were used to
culture astrocytes or glioma. The astrocytes were harvested from newborn rat pups, and
the glioma were cell line CRL-2303 ATCC. From the center two rows, 10 wells were
used to culture the cells and surrounding wells had sterile water added to prevent dry
outs. For glioma cells, 1.0ml of media was added to each well and then placed in the
incubator to warm. In the case of astrocytes, poly-L-lysine was added to the plates preaddition of media as described in Appendix C. This addition is required to ensure the
astrocytes have good adhesion to the plate29. Once the plates are being warmed, cells
were passaged from stock flasks used between passage 1-2030, 31.32 for glioma, and
passage 1-7 for astrocytes. Cell flasks first have the media and dead cells removed via
pipetting, and then 2.0ml of sterile PBS33 1X are added, and the flask gently swirled to
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wash. The PBS is subsequently removed and then 1.5ml of trypsin EDTA34 is added to
the flasks, and then they are placed back in the incubator for 5 minutes. After the 5
minutes, the flasks are visually examined by holding them up to the light, looking for the
free-floating cell sheets which are opaque with no remaining segments adhered to the
flask. Once the cells are fully detached, the cells are pipetted into a 15ml conical tube
along with 2ml of cell media and spun down in a centrifuge at 160 RCF for 8 minutes at
10°C. Once a cell pellet has been achieved the supernatant is removed and then 2.0ml of
media is added back to the tube. The cells are then vortexed, and using a
hemocytometer35, the average cell density is recorded. The cells were plated at the
desired density in each of the wells and in the flask, typically 5000 cells/ml of media36.
Once a plate has had the addition of the cells, in the case of glioma, it will be 5-7
days until the cells are 100% confluent while astrocytes will take 7-9 days. Having a cell
culture at approximately 90% confluence37 is optimal as it allows for maximum cells in a
field of view for microscopy that are still individually distinguishable. However, in terms
of MTT assay confluence is still relative; but since it relies on cellular metabolism, as
long as the cells have not diversified or grown in multi layered sheets, it is still utilizable
in the 90-100% confluence range38. The addition of materials in these experiments were
added 24 or 48 hrs. prior to imaging or assays in final concentrations of 20ug/ml. For
example, a plate of 10 wells with cells will have 2 wells with an addition of cell media, a
negative control, and 2 wells with the addition of CuNPs as a positive control; one each
at 24 and 48hrs. Lastly, 2 rows of 3 wells for the material of investigation, one set added
at 24hrs. and one set added at 48 hrs. prior to experimentation (pictured next page Figure
2-6-1).
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Figure 2-6-1: Standard example of a cell culture plate of astrocytes mid growth period
being observed as part of standard care. No materials have been added and the
surrounding wells can be seen containing sterile water to prevent dry outs.
Figure 2-6-2 was taken to show what most materials look like in suspension before
addition to cell cultures, as these are materials about to be added for the 24hrs. group and
have sat for 24hrs. approx. It also demonstrates that some material settles as shown in
Figure 2-6-2 on the following page, most prominently displayed in the case of CuNPs.
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Figure 2-6-2: 400ug/ml dilutions of materials and astrocyte media waiting to be added to
the cultures. These materials were mixed and refrigerated approx. 24hrs. before
photographing to allow some comparisons of settling to be shown. Left to right: cobalt
MOBs, copper nanoparticles, CuHARS, silicon dioxide nanoparticles and zinc MOBs.

2.7 MTT Assay
For MTT assay, a spectrophotometer was used in conjunction with the MTT powder
obtained from Sigma-Aldrich (St. Louis, MO, USA) along with the cell culture plate. The
protocol is written in Appendix E. The spectrophotometer used was a Genesys 20 from
Thermo Spectronic, at 630nM for glioma and 570nM for astrocytes. The instrument was
pre-warmed before use to avoid fluctuating bulb heat causing a drift in value. A max drift
in absorbance value recorded in a 1hr. period of idle time was +/- 0.003.
The purpose of MTT assaying cell cultures, pictured on the following page in Figure
2-7-1, was to assess the cells’ metabolism. The initial addition of yellow tetrazole is
reduced to formazan purple by the cells39, 40, and 41. The rate at which they are able to
process this is determined by their metabolism. Therefore, an injured or negatively
affected cell will not be able to metabolize as much tetrazole in 1hr as an otherwise
unaffected cell.
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Figure 2-7-1: A plate of astrocytes being prepared for MTT assay with 500ul of
iso2propanol alcohol added to dissolve the formazan crystals. Visual comparisons can be
made of different conditions at this time directly after addition of alcohol. For example,
the second column labeled CuNPs has a distinctly less purple hue than the controls of
zinc MOB areas. (First column).
2.8 Digital Microscopy
The majority of the digital microscopy was performed on one of two stations; a Leica
DMI 6000 B with light source Kubler Codix and powered by Leica software version 2.0
and run by a Windows 8 computer for DAPI staining. The other main station was an
Olympus IX 51 inverted microscope with a light source Olympus TH4-100 for white
light and Polychrome V for fluorescent light. This was run on a windows computer
version 8 operating the program Incytam 1 for calcium imaging.
2.9 Calcium Imaging
For calcium imaging, the first step was to warm two 15ml conical tubes of Locke’s
solution42. One tube was the wash and needed 475μl of Locke’s per well. The other tube
was labeled “loading solution” (6ml for 8 wells), and had 600μl per well. The loading
process typically took 1hr. in a 37°C incubator or 15 minutes in a 37°C water bath. Once
the loading tube was warmed in sterile conditions, 5µl of Pluronic acid43 was added, and
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vortexed looking for minor bubbles to signify thorough mixing. Then, with low light
conditions, 6µl of Flo 4AM44 was added and vortexed. Once the solution was prepared, a
plate was obtained and all media was gently removed so as not to disturb the cells45.
Next, 600μl of loading solution was added to the wells slowly so as not to lift the cells or
unduly stress them. This was repeated on all wells. Once all wells had their media
exchanged for loading solution, the cells were returned back to the incubator for 1hr.
In the meantime, all stimulants, such as ATP, experimentals, or Ionomycin were
prepared. Also in this time, the imaging systems equipment, if needed, began warming
up. When the 1hr. wait was up, the plate was retrieved and once again the solution was
gently removed, adding the 475μl of plain Locke’s, also known as the recovery solution,
and placed back in the incubator for 20 min to reduce stress. After the 20 min had
expired, the plate was ready for calcium imaging (pictured in the next page, Fig. 2-9-1).
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Figure 2-9-1: Above a phase light image from a calcium imaging session merged with a
pseudo color image of the same frame to indicate intensity of response. This frame was
taken after the addition of Ionomycin, a positive control showing maximum response.
2.10

DAPI Staining

DAPI is a technique that utilizes the fluorescent properties of the DAPI molecule46, 47
which selectively dyes the DNA of a cell, highlighting the nucleus and allowing
imaging48. Once a plate has been fixed for DAPI imaging, it will need the addition of
DAPI diluted in sterile water. A 1:300-fold dilution was used to see successful staining of
the nucleus. Exposure was set to 400ms with a gain of 3-fold in the “Ai4” setting. The
purpose of DAPI staining was to highlight the morphology of the nucleus for imaging.
By means of fluorescence, one can drastically increase the contrast between background
noise49, 50 and then observe changes in roundness and area, aided by computer software.
A drastic change in these values can indicate stress or abnormal growth. An example of
this would be a decreased value in roundness. Shown in Figure 2-10-1 on the next page, a
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flat adherent cell with processes will have a much more flattened nucleus51, and a higher
roundness value as compared to a near floating cell which will have a value close to 1.

Figure 2-10-1: Above (left) glioma cells grown 5 DIV and (right) a DAPI stain of the
same view. Note in the phase light image the variety of cell sizes and elongated
transparent nature of the cell body and processes indicating healthy adhesion to the flask.
Cells also lack a “halo” effect that may come from a cell becoming round as it lifts off the
surface causing light to bend.
2.11

Image Analysis and Data Normalization

For the series of images generated from calcium imaging along with results from
DAPI images, analysis and data normalization would need to be performed. In the case of
calcium imaging, data processing was performed on the same system that the images
were taken or a similar system with the same operating system and software version. We
began by bringing up the last image(s) in each wells’s recording. This was done in all
cases and the final stimuli was ionomycin 500nM; and, therefore, are the brightest
calcium signaling. Once on this frame we digitally circle an Area Of Interest (AOI) to
record the readings of a cell. It is important to keep the circle tight to the cell body, as
including excess background will increase noise and decrease reading accuracy, dropping
the overall value of intensity recorded over time. Once all AOIs in the frame have been
highlighted, the location and size were saved as an “.OBJ” file. The AOIs were then
copied to all frames in the session. Once this is done, we went through several various
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frames to ensure we did not have a floating cell obscuring values. A measurement at this
time can then be taken and saved as a separate file. This file can then be opened in a
separate window that is then copied directly into Excel. This data is simply a 2-axis table
of time of the frame vs which cell body recording the intensity of light recorded as a sum
of the area. I.e., one pixel at max value will have a value of ten, while a cell consisting of
ten of these pixels would have a sum of one hundred. In practice it is a vast array of pixel
values and often far more than ten pixels.
The data from the Excel sheet was then normalized to one at time zero for each cell.
This was performed by highlighting the first row of the table and creating an equation to
divide the “time=zero” value of a cell by itself, and fixing the value to this first for each
cell column. Once the first row is normalized, if done correctly, all values in the first
column should be equal to one. Then the highlighted region is transposed down through
time.
Lastly, the cells were filtered for responders vs non responders. Responders are cells
that responded to stimulus, as shown by control cells to be a value of 1.2-fold or more
baseline activity. The cells also typically recover towards baseline, the trend being a
negative control52, 53, vs. cells that only responded to ionomycin which is a positive
control54. All cells must respond to ionomycin to be considered alive. The filter of
responder was a post normalization value of 1.2-fold intensity pre-addition of ionomycin.
This includes the baseline time values, as changing values pre-stimulus often indicate
stress or complex behaviors; both are of interest for this study. This was done using
Excel, formatting values to highlight the chart in color and hand sorting cells that
responded. Once the responsive cells were sorted, an average would be generated from
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all cells of the same experimental conditions and plate. These averages are graphed and
displayed in Chapter 3 of this work.
For DAPI images, data analysis was performed on the same internet isolated
workspace as imaging was performed. First, we loaded a hard copy of Image Pro Plus
version 7.0. Next, the desired image was added to the software and the cells highlighted.
This can be done with one of two common ways. Either automatically contour bright
objects, in which the software would draw a link encircling objects of high luminescence
and display a red outline for the operator. The alternative method is to manually select
colors, in which case the operator will use an ink dropper icon to manually select all
colors of interest. This method allows the user to quickly create a black and white mask
of all cells. A disadvantage is that the dimmer colors cannot be selected, as it will rapidly
begin to occlude random areas of the image, as the filter becomes overly sensitive.
Regardless of which method the researcher uses, the next steps remain the same.
The software will undoubtedly blend, merge or join two separate cells. For this, the user
will make use of the “draw a line” function to draw a line between the start and finish of
cell clumps. The scale bar is often seen by the software as an AOI and must be removed
with the “toggle objects on and off” function. Once all corrections and editorial decisions
have been made, the user will select the measurements to display. In this study, area and
roundness were chosen for their indications of cell stress via nuclear morphology. Once
the measurements are displayed, “copy to clip board” is used to transfer the values to an
Excel file.
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Once in Excel, the averages of all cells of the same plate and conditions will be
generated for cell area and roundness and these two multiplied to generate the average
Nuclear Area Factor (NAF), as discovered and elaborated on by DeCoster56 .

CHAPTER 3
RESULTS

3.1 Cobalt MOBS
In the following tables, the MTT absorbance data for cobalt MOBs is displayed.
Three readings were taken per well. Routine blanking occurred to ensure the instrument
did not drift due to lamp heat. In the case of glioma, only 24hrs. controls were taken for
comparison. Note the decrease in absorbance values (decreasing symbolizing cell stress)
of the CuNPs*56 group, a positive control known to injure or stress cells, as shown in
Table 3-1-1 on the following page. The metabolism, as shown, is 43% for the CuNPs
which is considered a significant drop as most cells dropping under 50% have more
drastic effects than slow recovery such as, mass cell death, cell de-adhesion, or are
incapable of surviving and responding to environmental factors and stimuli.
For all groups following the table in Chapter 3, there are two ways to evaluate the
values relative to “time” or “controls average”. A columns value can be compared to just
the controls value at a single time point such as materials average absorbance at 24hrs.
compared to control at 24hrs. The other option is comparing the average of both the 24
and 48hrs. control group. As both controls grew simultaneously, the only difference in
the controls was the separate time points for the addition of media to simulate the effects
caused by the process of the addition of materials.
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3.1.1 Cobalt’s MOBs Impact on Cell Metabolism
Table 3-1-1: In the table below, we see the data for glioma cells raise 5 days in vitro
(DIV), plated at 5k cells per ml of media and dosed with 20ug/ml cobalt MOB particles.
The average values of the MOBs have been compared to the times of control to
normalize different unaltered cell populations. The average values of both controls have
also been merged together for a secondary comparison.
Control 24
Hrs.
0.736
0.741
0.741
0.678
0.682
0.681

Glioma Abs. Cobalt MOB @630nm 5k/ml, 20uG/ml
Control 48
CuNPs 24 CuNPs 48 Cobalt Mob 24
Cobalt MOB 48
Hrs.
Hrs.
Hrs.
Hrs.
Hrs.
0.272
0.552
0.521
0.282
0.565
0.524
0.287
0.577
0.527
0.332
0.699
0.517
0.324
0.701
0.537
0.322
0.702
0.552
0.656
0.559
0.661
0.571
0.662
0.574
0.710
0.303
0.642
0.542

Average

0.710

Relative
Health to
Time

100%

100%

43 ± 1%*

90 ± 2%

76 ± 1%

Relative
Health to
Controls
Average

100%

100%

43%*

90%

76%

In contrast, the “healthy, normal” astrocytes are much more fragile than the
cancerous glioma as shown and supported in the following tables of MTT data; having
lower astrocyte metabolism compared to glioma when exposed to stimuli such as the
copper here and 24hrs. cobalt. Shown below in Table 3-1-2, note that the absorbance was
taken at 570nm, and this was done to increase resolution of the readings for astrocytes.
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Table 3.1.2: In the table below, we see the data for astrocyte cells raise 7 days in vitro
(DIV), plated at 5k cells per ml of media and dosed with 20ug/ml cobalt MOB particles.
The average values of the MOBs have been compared to the times of control to
normalize different unaltered cell populations. The average values of both controls have
also been merged together for a secondary comparison.

Average
Relative
Health to
Time
Relative
Health to
Controls
Average

Astrocyte Abs. Cobalt MOB @570nm 5k/ml, 20uG/ml
Control 24
Control 48 CuNPs
CuNPs
Cobalt Mob 24 Cobalt MOB 48
Hrs.
Hrs.
24 Hrs.
48 Hrs.
Hrs.
Hrs.
0.508
0.417
0.132
0.131
0.323
0.36
0.508
0.417
0.131
0.131
0.323
0.36
0.508
0.417
0.131
0.132
0.323
0.361
0.442
0.334
0.443
0.334
0.442
0.333
0.385
0.289
0.386
0.29
0.385
0.291
0.508
0.417
0.131
0.131
0.414
0.328

100%

100%

26%

31%

81 ± 2%

79 ± 1%

110%

90%

28%

28%

89%

71%

3.1.2 Cobalt MOBs Impact on Cell Morphology
On the next page are DAPI staining images for glioma that were exposed to cobalt
MOBs. Of note are the larger cell nuclei often present, on the next page in Figure 3-1-1.
After these images, tables display the average values of area, roundness and NAF of the
conditional groups from which these images were taken, Table 3-1-3.
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Figure 3-1-1: The above images (left) a phase light image of Cobalt MOBs 48hrs.
exposure and (right) was a DAPI stain of glioma cells grown 5 DIV fixed and then
stained to image. Note the larger than normal nuclei that in some Co MOB cultures were
present. Scale bar 50µm.
Below in Table 3-1-3, we see a decrease in the cobalt roundness values compared
to the controls.
Table 3-1-3: This is the DAPI stain data for glioma cells.
Area

Roundness NAF

Average for Controls (Co)

426.6166 1.308684

558.3064

Average for Co 24hrs

421.2918 1.268579

534.442

Average for Co 48hrs

448.0405 1.249056

559.6279
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Below we see in Figure 3-1-2 two images for astrocytes exposed to cobalt MOBs
for 48Hrs. These cells had a similar trend of being larger than their control counterparts.
Also note the presence of the Co MOB particles.

Figure 3-1-2: The above images (left) aphase light image of Cobalt MOBs 48hrs.
exposure and (right) was a DAPI stain of astrocyte cells grown 5 DIV fixed and then
stained to image. Note the larger than normal nucleus that in some Co MOB cultures
were present. This feature was also present in the astrocytes and can be shown in table
3.1.4. Scale bar = 50µm.
Below in Table 3-1-4 we see the DAPI nuclear stain data for astrocytes. Note the
higher average NAF and area for both cobalt groups.
Table 3-1-4: This is the DAPI stain data for astrocyte cells.
Area

Roundness

NAF

Average For Control

1251.917

1.2750953

1596.313

Average For Cobalt 24hrs

1443.374

1.21280342

1750.529

Average For Cobalt 48hrs

1289.618

1.2670243

1633.977
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3.1.3 Cobalt MOBs Impact on Cell Response
Below is a graph of the calcium imaging data representing the cobalt MOBsexposed glioma cells and their dynamic calcium response to Ionomycin, Figure 3-1-3.
Red arrows indicate the time points at which stimuli were added. In this case, stimuli
were ATP 1µM and Ionomycin 250nM.

Cobalt Ca++ intensity response vs ATP 1uM, Iono 250nm,
& Iono 500nM @ 24 and 48hrs of exposure (Responders
only)
IONO

1

ATP

6

1

5

Intensity

2

4
3
2
1
0
0

50

100

150

200

250

Seconds, 4 per recording

300

350

IONO

400

3
1

Control Avg.

Co+ 24Hr Avg.

Co+ 48Hr Avg.

Figure 3-1-3: Calcium response data for glioma cells exposed to cobalt MOBs 24 and 48
hrs. compared with a control well with no additions.
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3.2 CuHARS
3.2.1 CuHARS MOBs Impact on Cell Metabolism
In the following tables, the MTT absorbance data for CuHARs is displayed. Three
readings were taken per well. The relative health of the glioma versus the astrocytes is
noteworthy; Table 3-2-1/2 on the next pages. A mechanism that selectively reduces the
metabolism of glioma and has no, nominal, or manageable effects on astrocytes would be
considered a successful treatment for cancerous tissues at this scale.
Table 3-2-1: In the table below, we see the data for glioma cells raise 5 days (DIV),
plated at 5k cells per ml of media and dosed with 20ug/ml CuHARs particles. The
average values of the MOBs have been compared to the times of control to normalize
different unaltered cell populations. The average values of both controls have also been
merged together for a secondary comparison.

Average

Glioma Abs. CuHARs MOB @630nm 5k/ml, 20uG/ml
Control 24
Control 48
CuNPs 24
CuNPs 48
CuHARs 24
CuHARs 48
Hrs.
Hrs.
Hrs.
Hrs.
Hrs.
Hrs.
0.798
0.693
0.419
0.289
0.641
0.597
0.803
0.701
0.423
0.294
0.657
0.601
0.807
0.709
0.425
0.3
0.668
0.607
0.444
0.444
0.447
0.446
0.451
0.446
0.609
0.539
0.612
0.55
0.615
0.55
0.803
0.701
0.422
0.294
0.572
0.531

Relative
Health to
Time

100%

100%

53%*

42%*

71 ± 3%

76 ± 2%

Relative
Health to
Controls
Average

107%

93%

56%

39%

76%

71%
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Below in Table 3-2-2, keeping in mind that the values for CuHARs were 71
±3%,76 ± 2%, note the higher values that are highlighted representing absorbance for
astrocytes.
Table 3-2-2: In the table below, we see the data for astrocyte cells raise 7 (DIV), plated
at 5k cells per ml of media and dosed with 20ug/ml CuHARs particles. The average
values of the MOBs have been compared to the times of control to normalize different
unaltered cell populations. The average values of both controls have also been merged
together for a secondary comparison.
Astrocyte Abs. CuHARs MOB @570nm 5k/ml, 20uG/ml
Control 24
Control 48
CuNPs 24
CuNPs 48
CuHARs 24
Hrs.
Hrs.
Hrs.
Hrs.
Hrs.

Average
Relative Health to
Time
Relative Health to
Controls Average

CuHARs 48
Hrs.

0.455

0.429

0.326

0.172

0.393

0.394

0.455

0.43

0.326

0.172

0.395

0.395

0.458

0.437

0.328

0.175

0.397

0.398

0.327

0.233

0.327

0.235

0.33

0.235

0.374

0.42

0.375

0.422

0.378

0.423

0.456

0.432

0.327

0.173

0.366

0.351

100%

100%

72%

40%

80 ± 1%

81 ± 3%

103%

97%

74%

39%

82%

79%
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3.2.2 CuHARS MOBs Impact on Cell Morphology
Below are in Fig. 3-2-1, are DAPI staining images for glioma that were exposed
to CuHARs. Of note is the clear presence of CuHARs structures, as shown by fine black
lines in the phase light imagery. After these images, tables display the average values of
area, roundness and NAF of the conditional groups from which these images were taken.

Figure 3-2-1: The above images (left) a phase light image of CuHARs 48hrs. exposure
and (right) was a DAPI stain of glioma cells grown 5 DIV fixed and then stained to
image.
Below we see the DAPI stain data of the cell nuclei in Table 3-2-3 which shows
decrease of roundness in CuHARs, which could suggest less stressed cells.
Table 3-2-3: DAPI stain data for glioma cells.
Area

Roundness NAF

Average For Controls (CuHARS)

448.5647 1.294571

580.6989

Average For CuHARS 24Hrs

611.972

1.336157

817.6908

Average For CuHARS 48Hrs

519.1178 1.356752

704.3139
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Below in Figure 3-2-2, we see images from the CuHARs 24hrs. exposure groups
of astrocytes. In the left phase light image, note the presence of materials depicted as the
dark black lines.

Figure 3-2-2: The above images (left) a phase light image of CuHARs 48hrs. exposure
and (right) was a DAPI stain of astrocyte cells grown 5 DIV fixed and then stained to
image.
Below in Table 3-2-4, we see the astrocyte DAPI staining data for CuHARs. Note
the similar values of NAF for all groups and the near identical sizes for CuHARs.
Table 3-2-4: DAPI stain data for astrocyte cells.
Area

Roundness

NAF

Average For Control

1251.917

1.2750953

1596.313

Average For CuHARs 24hrs

1206.891

1.3181766

1590.896

Average For CuHARs 48hrs

1206.452

1.35148373

1630.501
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3.2.3 CuHARs Impact on Cell Response
Below is a graph representing the CuHARs exposed glioma cells calcium imaging
data, Figure 3-2-3. Red arrows indicate the time points at which stimuli were added. In
this case stimuli #1/2 were ATP 1µM, and #3 Ionomycin 250nM. Note the peaks of
stress.

CuHARs calcium data
3.5
3

Intensity

2.5

ATP
2
1.5
1

IONO

ATP
0.5
0

100

200

300

400

500

Time in seconds
6 Hr Exp. Avg.

9 Hr Exp. Avg.

48 Hr Exp. Avg.

9 Hr control Avg.

24 Hr Exp. Avg.

Figure 3-2-3: In the figure above, we see the calcium response data for glioma cells
exposed to CuHARs MOBs 24 and 48 hrs. compared with a control well with no
additions.

600
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3.3 Zinc MOBs
3.3.1 Zinc MOBs Impact on Cell Metabolism
In the following tables, the MTT absorbance data for zinc MOBs is displayed. Of
interest is the increase on initial metabolism of zinc-exposed glioma cells in the 24hrs.
group. While several MOBs cause a higher 48hrs. group value than the 24hrs. group and
vice versa, there has not been another MOB material showing increase in absorbance to
this extent**.
Table 3-3-1: In the table below, we see the data for glioma cells raise 5 (DIV), plated at
5k cells per ml of media and dosed with 20ug/ml Zinc MOB particles. The average
values of the MOBs have been compared to the times of control to normalize different
unaltered cell populations. The average values of both controls have also been merged
together for a secondary comparison.

Average

Glioma Abs. Zinc MOB @630nm 5k/ml, 20uG/ml
Control 24
Control 48
CuNPs 24
CuNPs 48
Zinc 48
Hrs.
Hrs.
Hrs.
Hrs.
Zinc 24 Hrs.
Hrs.
0.464
0.454
0.271
0.184
0.761
0.383
0.467
0.456
0.272
0.185
0.769
0.387
0.468
0.458
0.272
0.186
0.79
0.389
0.502
0.334
0.503
0.337
0.505
0.342
0.631
0.539
0.658
0.547
0.667
0.555
0.466
0.456
0.272
0.185
0.643
0.424

Relative
Health to
Time

100%

100%

58%

41%

138 ± 4%**

93 ± 3%

Relative
Health to
Controls
Average

101%

99%

59%

40%

139%

92%
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Below in Table 3-3-2 we see the lowest recorded CuNPs values. Also of slight
obscurities is the value for the averaged controls compared to the Zn 48hrs. in the most
bottom left cell, which suggest the 48 hrs. astrocytes out-performed the glioma by 3%.
Table 3-3-2: In the table below, we see the data for astrocyte cells raise 7 (DIV), plated
at 5k cells per ml of media and dosed with 20ug/ml Zinc MOB particles. The average
values of the MOBs have been compared to the times of control to normalize different
unaltered cell populations. The average values of both controls have also been merged
together for a secondary comparison.

Average

Astrocyte Abs. Zinc MOB @570nm 5k/ml, 20uG/ml
Control 24
Control 48
CuNPs 24
CuNPs 48
Zinc 24
Zinc 48
Hrs.
Hrs.
Hrs.
Hrs.
Hrs.
Hrs.
0.432
0.486
0.106
0.097
0.464
0.469
0.43
0.486
0.106
0.097
0.466
0.466
0.431
0.485
0.106
0.098
0.471
0.463
0.349
0.491
0.349
0.493
0.35
0.493
0.252
0.356
0.256
0.352
0.256
0.353
0.431
0.486
0.106
0.097
0.357
0.437

Relative
Health to
Time

100%

100%

25%

20%

83 ± 3%

90 ± 2%

Relative
Health to
Controls
Average

94%

106%

23%

21%

78%

95%
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3.3.2 Zinc MOBs Impact on Cell Morphology
Below, Fig 3-3-1, are DAPI staining images for glioma that were exposed to zinc
MOBs. Of note is the variety of cell shapes, sizes, and brightness. The tables following
display the average values of area, roundness, and NAF of the conditional groups.

Figure 3-3-1: The above image (left) is a phase light and (right) a DAPI stain of glioma
cells grown 5 DIV exposed to Zn MOBs for 48hrs. fixed and then stained to image.
In the below Table 3-3-3, we see zinc DAPI stain data for glioma. Note the
similar values between both zinc groups and little change in the roundness, but a large
change in area of Zn groups.
Table 3-3-3: This is the DAPI stain data for glioma cells.
Area

Roundness NAF

Average for Controls (Zn)

511.996

1.199097

613.8968

Average for Zn 24hrs

464.4684 1.198775

556.7929

Average for Zn 48hrs

459.3157 1.189434

546.3257

Below in Figure 3-3-2, we see a DAPI stain of astrocyte cells exposed to zinc
MOBs for 48hrs.
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Figure 3-3-2: The above image (left) is a phase light and (right) a DAPI stain of
astrocyte cells grown 5 DIV exposed to Zn MOBs for 48hrs. fixed and then stained to
image.
In contrast for the astrocytes data shown below in Table 3-3-4, we see differing
values between both time points for the zinc group.
Table 3-3-4: This is the DAPI stain data for astrocyte cells.
Area

Roundness

NAF

Average For Control

1251.917

1.2750953

1596.313

Average For Zinc 24hrs

1085.653

1.38035696

1498.588

Average For Zinc 48hrs

1282.989

1.32228516

1696.478
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3.3.3 Zinc MOBs Impact on Cell Response
Below in Fig. 3-3-3, is a graph representing the zinc MOBs exposed glioma cells.
Red arrows indicate the time points at which stimuli were added. In this case stimuli were
#1/2 ATP 1µM and #3 Ionomycin 250nM.

The effects of Zinc MOBs @ 20ug/mL
over time
3
1

4

2

Intensity
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1

2
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100

200
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48 Hr Exp. Avg.

Figure 3-3-3: In the figure above, we see the calcium response data for glioma cells
exposed to zinc MOBs 24 and 48 hrs. compared with a control well with no additions.
Note the stress peaks in the 48hrs group and lack of response from the 24hrs group.
3.4 Silicon Dioxide NPS
3.4.1 Silicon NPS impact on Cell Metabolism
On the next page in Table 3-4-1, the MTT absorbance data for silicon dioxide
nanoparticles exposed glioma is displayed. Note the similarity of values of the SiO2
compared to that of the controls.
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Table 3-4-1: In the table below, we see the data for glioma cells raise 5 (DIV), plated at
5k cells per ml of media and dosed with 20ug/ml SiO2 particles. The average values of
the MOBs have been compared to the times of control to normalize different unaltered
cell populations. The average values of both controls have also been merged together for
a secondary comparison.

Average
Relative
Health to
Time
Relative
Health to
Controls
Average

Glioma Abs. SiO2 @630nm 5k/ml, 20uG/ml
Control 24
Control 48
CuNPs 24
CuNPs 48
SiO2 24
SiO2 48
Hrs.
Hrs.
Hrs.
Hrs.
Hrs.
Hrs.
0.672
0.728
0.435
0.223
0.721
0.668
0.679
0.73
0.44
0.236
0.725
0.674
0.683
0.732
0.443
0.239
0.729
0.682
0.665
0.635
0.671
0.647
0.679
0.658
0.643
0.821
0.661
0.828
0.663
0.832
0.678
0.730
0.439
0.233
0.684
0.716

100%

100%

65%

32%

101 ± 1%

98 ± 3%

96%

104%

62%

33%

97%

102%

Once again, as shown in Table 3-4-2 on the following page, we see the astrocyte
data contains similar values for the SiO2 groups compared to the controls.
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Table 3-4-2: In the table below, we see the data for glioma cells raise 7 (DIV), plated at
5k cells per ml of media and dosed with 20ug/ml SiO2 particles. The average values of
the MOBs have been compared to the times of control to normalize different unaltered
cell populations. The average values of both controls have also been merged together for
a secondary comparison.
Astrocyte Abs. SiO2 @570nm 5k/ml, 20uG/ml
Control 24
CuNPs 24
CuNPs 48
Hrs.
Control 48 Hrs. Hrs.
Hrs.
0.598
0.685
0.535 0.799
0.603
0.688
0.539 0.804
0.604
0.688
0.539 0.807

Average
Relative
Health to
Time
Relative
Health to
Controls
Average

SiO2 24
SiO2 48
Hrs.
Hrs.
0.733
0.607
0.731
0.608
0.732
0.608
0.719
0.636
0.723
0.639
0.725
0.64
0.382
0.737
0.385
0.74
0.387
0.743
0.613
0.662

0.602

0.687

0.538

0.803

100%

100%

89%

117%

102 ± 6%

96 ± 2%

93%

107%

83%

125%

95%

103%

3.4.2 Silicon NPS Impact on Cell Morphology
Following are DAPI staining images for glioma that were exposed to SiO2 NPS.
Of note is the cell density of Fig. 3-4-1 (SiO2) on the following page compared to that of
earlier Figure 2-10-1 (a control). After Fig. 3-4-1, tables display the average values of
area, roundness and NAF of the conditional groups from which these images were taken.
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Figure 3-4-1: The above images (left) a phase light image of SiO2 nanoparticles 24hrs.
exposure and (right) was a DAPI stain of glioma cells grown 5 DIV fixed and then
stained to image. Note the diversity of cell size and transparent bodies sans “halo”.
Below in Table 3-4-3, note the higher NAF and area values of the silicon groups
compared to the controls.
Table 3-4-3: This is the DAPI stain data for glioma cells.
Area

Roundness

NAF

Average for Controls (SI/np)

249.6741

1.455241

363.3361

Average for Si 24hrs

325.1977

1.298094

422.1371

Average for Si 48hrs

289.3184

1.429312

413.5264

Below in Figure 3-4-2, we see a DAPI stain and phase light image of astrocyte cells
exposed to SiO2 NPs for 48hrs. Note the variety of cells size and shape along with an
observed larger size. This was the largest single group of astrocytes by area.
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Figure 3-4-2: The above images (left) a phase light image of SiO2 nanoparticles 24hrs.
exposure and (right) was a DAPI stain of astrocyte cells grown 5 DIV fixed and then
stained to image.
Below, Table 3-4-4, we see the DAPI stain values of SiO2 NPS on astrocyte cells.
Table 3-4-4: This is the DAPI stain data for astrocyte cells.
Area

Roundness

NAF

Average For Control

1251.917

1.2750953

1596.313

Average For SiO2 24hrs

1120.047

1.29393276

1449.265

Average For SiO2 48hrs

1492.218

1.25746345

1876.409

3.4.3 Silicon NPS Impact on Cell Response
On the next page, Fig. 3-4-3, is a graph representing the SiO2 NPS-exposed
glioma cells. Red arrows indicate the time points at which stimuli were added. In this
case, stimuli were #1 ATP 1µM and #2/3 Ionomycin 250nM. Of note is the 1.2x baseline
intensity response of the SiO2 exposed cells. The data for only living and responsive cells
are displayed. The graph has been cropped to provide resolution of the SiO2 groups, and
the controls post-ionomycin data is not displayed. Observe the third stimulus which
seems to show the decrease of cell signaling from the 48hr. group, which could be an
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error. However, the SiO2 NPS are hollow and can adsorb as well as absorb, possibly uptaking some stimulus compounds. SiO2 NPS in the 48 groups could have had a higher
remaining mass of materials during the imaging session.
3
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Figure 3-4-3: In the figure above, we see the calcium response data for glioma cells
exposed to silicon dioxide nanoparticles 24 and 48 hrs. compared with a control well with
no additions.
3.5 Copper Nanoparticles
3.5.1 The Impact of CuNPs on Cell Metabolism
On the next page in Table 3-5-1, the MTT absorbance data for CuNPs is
displayed. Note the values of the CuNPs compared to the CuHARs, keeping in mind that
the concentration of the CuNPs is half by mass compared to CuHARs.
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Table 3-5-1: In the table below, we see the data for astrocyte cells raise 7 (DIV), plated
at 5k cells per ml of media and dosed with 20ug/ml CuHARs particles. The average
values of the MOBs have been compared to the times of control to normalize different
unaltered cell populations. The average values of both controls have also been merged
together for a secondary comparison.
Astrocyte Abs. CuHARs @570nm 5k/ml, 20uG/ml for CuHARs 10ug/ml for CuNPs
Control 24
Control 48
CuNP 24
CuNP 48
CuHARs 24
CuHARs 48
Hrs
Hrs
Hrs
Hrs
Hrs
Hrs
0.624
0.302 0.539
0.644
0.56
0.479
0.624
0.299 0.539
0.641
0.56
0.479
0.626
0.298 0.539
0.64
0.557
0.475
0.58
0.59 0.54
0.582
0.578
0.684
0.582
0.589 0.538
0.578
0.576
0.684
0.582
0.589 0.538
0.58
0.577
0.681

Average
Relative
Health to
Time
Relative
Health to
Controls
Average

0.603

0.445

100 ± 1%

100 ± 6%

115%

85%

0.539

0.611

0.568

0.580

89 ± 0%

137 ± 1%

94 ± 0%

131 ± 5%

103%

117%

108%

111%

3.5.2 CuNPs Impact on Cell Morphology
On the next page, Figure 3-5-1, are DAPI staining images for glioma that were
exposed to CuNPs. Note the frequency of the “halo” effect, which indicates lift due to
extreme stress on cells in the phase light image. After these images, tables display the
average values of area, roundness and NAF of the conditional groups from which these
images were taken.
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Figure 3-5-1: The above images (left) a phase light image of CuNPs 24hrs. exposure and
(right) was a DAPI stain of glioma cells grown 5 DIV fixed and then stained to image.
Note the smaller, round cell bodies and “Halo” effect around objects indicating lift.
Below in Table 3-5-2, we see the CuNPs data for glioma cells. Note the increase
in NAF values for the CuNPs groups.
Table 3-5-2: This is the DAPI stain data for glioma cells.
Area

Roundness NAF

Average for Controls (SI/np)

249.6741 1.455241

363.3361

Average for CuNPs 24hrs

271.3318 1.51168

410.1669

Average for CuNPs 48hrs

311.1152 1.383619

430.4647

On the next page in Figure 3-5-2, we see a DAPI stain and phase light image of
cells exposed to CuNPs for 48hrs. Note the non-discreet haze of blue as opposed to the
usual oval packet. This is likely free floating nuclear material from ruptured cells. Also
note the presence of materials.

47

Figure 3-5-2: The above images (left) a phase light image of CuNPs 24hrs. exposure and
(right) was a DAPI stain of glioma cells grown 5 DIV fixed and then stained to image.
Note the none discreet haze of blue opposed to the usual oval packet. This is likely free
floating nuclear material from ruptured cells.
In contrast to the glioma, the astrocytes have more of a trend in the DAPI stain
data with both CuNPs groups having a large decrease in area values and lower NAF, but
higher roundness values. This data is shown below in Table 3-5-3.
Table 3-5-3: This is the DAPI stain data for astrocyte cells.
Area

Roundness

NAF

Average For Control

1251.917

1.2750953

1596.313

Average For CuNPs 24hrs

431.7826

1.38573555

598.3365

Average For CuNPs 48hrs

890.7727

1.49013525

1327.372
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3.5.3 CuNPs Impact on Cell Response
Below is a graph representing the CuNPs-exposed glioma cells. Red arrows
indicate the time points at which stimuli were added. In this case, stimuli were # 1 ATP
1µM and #2/3 Ionomycin 250nM. Of note is rapidness and intensity of the 48hrs.
exposure group, indicating stress compared to that of the control and 24hrs. group in
Figure 3-5-2 at the first addition.
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Figure 3-5-3: In the figure above, we see the calcium response data for glioma cells
exposed to copper nanoparticles 24 and 48 hrs. compared with a control well with no
additions. Note the rapid response of the 48hrs. group and the high intensity peak
indicating stress.

CHAPTER 4
DISCUSSION
Below is Table 4-1-1, summarizing the comparative effects of each material57
from Chapter 3.
Table 4-1-1: In the table we see a summary of major qualities of each material on cells
compared to controls. The CuNPs in the table will reference them as a negative control at
20µg/ml not the 10µg/ml experiment. The format presented is follows G1,2/A3,4.
1=glioma at 24hrs, 2= glioma at 48hrs, 3= astrocytes at 24hrs and 4=astrocytes at 48hrs.
MTT (24/48)

Calcium

Observed Color

Settling

Degradability

imaging
Cobalt Mobs

G--/A--

stimulative

Yellow/Brown

++

/

CuHARs

G--/A--

stimulative

Baby blue

++

++

Zinc MOBs

G+-/A--

stimulative

White

+

+++

SiO2 NPS

+/- 2% neutral

suppressive

White

+++

----

CuNPs

EXTREMELY

Hyper

Grey/Ink

+++

+++

NEG.

stimulative/
suppressive
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4.1 The Impact of Cobalt MOBs on Cells
As shown earlier in Table 3-1-1, the cobalt MOB had a detrimental effect on the
glioma cells reducing their metabolism to 90% and 76% for 24 and 48hrs. respectively.
The healthy astrocyte cells were also negatively affected, being reduced to 89% then 71%
as shown in Table 3-1-2. This impact on the astrocytes suggests that, with time, the
cancerous glioma may be able to better cope with the cobalt MOB treatment.
In Figure 3-1-3, we see the calcium imaging data for cobalt on glioma. When
comparing the response to ATP 1μM, the longer the cells were exposed to MOBs, the
greater the intensity of response from the cells. At 48 hours the intensity of response was
~2.25 fold greater. The higher the intensity of response, the more likely a cell is to be
stressed. At 250nm of ionomycin, the 24hrs. response takes over as the most prominent
followed shortly by the 48hrs. and finally 2/3 the intensity of response was the control
group. Subsequent 500nm of ionomycin showed similar minor increases of response from
all groups.
The DAPI stains revealed some interesting morphologies of cobalt MOB exposed
glioma cells. The most stand-out characteristic observed was the presence of much larger
than normal cells. At first, I believed this to be a field-of-view issue catching outliers.
However, in every well while not prevalent and predominant, the enlarged Co-exposed
cells were significantly present. This was the condition that most fell in line with the
initial hypothesis of the effects of MOBs; minor stress, an array of healthy and stressed
morphologies. The “halo” effect is present on some cells but not all. In fact, when
looking between the left and right of the presented image for cobalt MOBs in phase light
(Figure 3-1-2), it’s almost a tale of two cites. On the left, it is hard to separate from the
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background because the cells are so well adhered; on the right shows the beginning signs
of significant stress. The astrocytes also shared the trend of increased cell size visually,
Table 3-1-4, and numerically displayed this in area and NAF. While in roundness both
were lower than control, suggesting possible osmotic swelling which would also explain
increase in area.
4.2 The Impact of CuHARs on Cells
Most fascinating was the MTT metabolism data from CuHARs. The metabolism
of astrocytes out performed that of the glioma by a minimum of 5%, Table 3-2-1/3-2-2.
This suggest that the copper-based MOB is possibly capable of undermining the stability
of glioma control over a multicell-type environment.
These results were then cross examined with a second MTT test comparing the
standard dosage 20µg/ml of CuHARs vs. only 10ug/ml of CuNPs. This was done not
only to increase the data pool on this subject, but also to support the claim that MOBs are
less harsh than their regular nanoparticle counterparts.
The secondary reason for this is that the exact composition of both is unknown;
that is to say that while both have copper, not all 20μg/ml is copper. With rough
approximations of each materials’ copper content, see Figure 2-2-(1-5), by halving the
amount of CuNPs it is fairly certain the CuHARs would have less free copper ions at any
moment and similar amounts of copper by mass. The effects would then be further
isolated to the CuHARs having a slowed reaction kinetic due to reduced surface area per
mass. For example, assuming all CuNPs are CuO2, the least copper bearing form, any
mass would be 66.51% copper. Opposite is CuHARs in which the most copper bearing of
the proposed structures would be 34.41% copper mass. Now, these numbers applied to
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the 20µg/ml of CuHARs vs. only 10μg/ml of CuNPs would put the mass of copper
present at similar levels, slightly more in the CuHARs. The data seems to agree with this
in Table 3-5-1, showing they are similar in relative MTT health.
However, this is when the chemistry is most in favor to disprove the hypothesis
that raw nanoparticles are less impactful on cell health than a MOB counterpart. In reality
the CuNPs used were an unknown mixture of CuO and CuO2, and the CuHARs were
likely a mix of all three proposed structures that can contain possibly unreacted cysteine
or have other unknown hydrocarbon R-groups.
The CuHARs were being examined with calcium imaging much earlier in the
course of my research at a level of detail that would not be continued, as it did not allow
time to investigate other materials or cell lines at acceptable levels. That said, the level of
insight on these groups is particularly fascinating in regards to glioma calcium imaging
with not two time points, but four. The trend we see in Figure 3-2-2 at the first 1μM ATP
stimulus through time exposed to CuHARS is that the cells have an initial suppression
followed by agitation, and then progressively lower response, more so than the six hours’
group (200/220 total cells responding). The second 1μM ATP response is similar in
regards to the six- and nine-hour time points (63/66 total cells responding), but at 24
hours, the group (156/166 total cell responding) never had a significant recovery and just
raised the plateau of agitation. Meanwhile the 48 hours’ group (116/132 total cells
responding) went from a low response, to the first stimulus, to having a greater intensity
than the control group.
When observing the DAPI data in Table 3-2-3, the glioma had increased values in
all regards compared to controls. This suggests a possible slight stunting in early

53
development followed by a recovery. The astrocytes in Table 3-2-4 have an extremely
consistent value for area and higher degrees of roundness when compared to controls. In
comparison to control in all fields, they are fairly similar.
4.3 The Impact of Zinc MOBs on Cells
Zinc is prevalent in the body, used in our zinc finger proteins for critical roles in
DNA and RNA handling along with transcription58. It is also the second most common
trace metal, only bested by iron. Lack of zinc can also cause anemia, fainting, dietary
uptake issues, and nervous system failures59.
Zinc MOBs exposed glioma had an unusual reaction, with an initial spike in
metabolism at 24hrs. to 139% (Table 3-3-1) then dropping to 92% at 48hrs. While this
trend may seem to be the source of under/overdosing, it is not too dissimilar from
conditions such as fever where metabolism is raised to fight adverse conditions.
However, just as with fevers, this state is not sustainable and then collapses to a lower
rate. Also, of slight curiosity is the astrocytes (Table 3-3-2) which dropped to 78% but
seemingly recovered to 95%; above the glioma by 3%.
In terms of glioma calcium response, the 24hrs. group was suspected to be dead;
but, ionomycin and review of the calcium video data suggests that the cells are heavily
suppressed, as there are only minor responses. While poorly understood, we know Zn is
capable of suppressing certain protein expressions and transcriptions of RNA60.
Countering this is the trend at 48hrs., showing a very immediate response to the first
stimulant compared to most glioma controls; almost like a hair trigger. While the
intensity of the response did not exceed that of the control groups, this behavior is
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abnormal. The secondary stimulus also shows a minor reaction, showing the cells were
still capable of resisting the effects of ionomycin as a healthy cell sometimes can.
When observing the DAPI data for the glioma cells in Table 3-3-3, it seems to
have negatively impacted the glioma in all categories; most significantly in many cells’
area. When turning our attention to Table 3-3-4 for the astrocyte data, we see a more
exciting trend for the initial astrocytes in the 24 hrs. Zn MOBs group. These do not
perform as well in all categories, but seem to improve by the 48hrs. group surpassing the
controls, possibly suggesting recovery. In this stand-out observation, Zn MOBs seem to
also be capable of selectively targeting glioma over astrocytes
4.4 The Impact of Silicon Dioxide Nanoparticles on Cells
The silicon dioxide, Tables 3-4-1/3-4-2, showed an expected low deviation of
results (max standard deviation of the mean being 5% between cell types). All results for
the experiments hovered around 100%, supporting the neutrality of SiO2.
The DAPI stains of glioma also seemed to confirm this, having a vast array of cell
types, sizes and good adhesion visually, Fig 3-4-1. Numerically in Table 3-4-3, we see
the data for glioma DAPI stains which suggest the glioma are out-performing the controls
in area and NAF. The astrocytes in Table 3-4-4 at 24hrs. are negatively impacted
compared to controls and at 48hrs. which are positively impacted.
In direct conflict were the results on the glioma from calcium imaging sessions,
which showed that it entirely suppressed a response from the SiO2 groups. While they did
respond to ionomycin, indicating their viability as a sample, it was significantly reduced
compared to that of the control group. These results combined could suggest that SiO2
nanoparticles can insulate cells from rapid changes in the environment. While the 24hrs.
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group did continue to increasingly respond to the ionomycin until the end of the
recording session, the 48hrs. group did not. The SiO2 NPS used here are hollow and can
adsorb as well as absorb, and possibly could be taking up some stimuli molecules. Also,
the better incorporated SiO2 NPS could have had a higher remaining mass during the
imaging session.
4.5 The Impact of Copper Nanoparticles on Cells
As an industry control, the CuNPs effects should be evaluated as a comparison for
other materials effects. As show in most tables in Chapter 3, CuNPs significantly reduced
the metabolism of both cells. When averaged by health across all experiments, the 24hr.
exposure reduced by 54% in glioma and 53% in astrocytes. Similarly, for the 48hr. group,
glioma dropped to 38% and astrocytes to 31%. These effects were consistent with the
literature56.
Glioma DAPI data, Table 3-5-2 on the CuNPs revealed extremely damaged
morphologies. Typically, broad, flat blades of cell processes had become spindly spider
webs. Once, hard-to-distinguish nuclei became swollen beads on a string of detaching
extremities. The “halo” of light suggests the near release of all cells present. Mind that all
DAPI stains are done after fixation and a wash, meaning the “worst” cells are already
removed. These are simply the next group whose average was just good enough to stick
and be used. Of the cells present in this observation, 436 were in the 48hrs. group, 430
cells in the 24hrs group, and 2,522 cells in the control group of this plate.
The astrocytes showed extreme damage as well in Figure 3-5-3. It can be seen
that the once discreet star like regions of cells have now gone super nova (ruptured) into
loose nebulas; their nuclear material scattered into the surrounding area.

CHAPTER 5
CONCLUSIONS AND FUTURE WORKS
5.1 Conclusions
In regards to the earlier hypothesis made on cells, SiO2 had a minimal impact on
the cells health only having a deviation +/- 3% of relative normal metabolism (Figure 34-1/2). This was also on display in the DAPI and phase light imaging with a fairly dense
and varying adherent morphologies of cells observed (Figure 3-4-1). However, the
calcium imaging data available (Figure 3-4-2) suggests it may be capable of suppressing
immediate response to the environment; this being counter to what was expected and
known of other brain cells61.
Cobalt MOBs in all tests showed signs of stress, and while the calcium imaging
data may suggest mild long-term suppression, when combined with the MTT results it is
suggested that astrocytes are more heavily suppressed. Also, the DAPI data in accord I
would not recommend it at the current 20μg/ml dosage to be further studied or utilized, as
the effects were too harsh. This supports the earlier hypothesis that Co MOBS would be
harsher than CuHARs, but less harsh than CuNPs.
The zinc was capable of showing 24hr. group suppression followed by signs of
recovery at 48hrs. in the calcium imaging data and, coupled with the MTT data, this
seems possible. However, the key factor for my recommendation of further study is the
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DAPI data. When comparing the two, the astrocytes seem to have had a less negative
response when compared to the glioma from examining roundness in Table 3-3-4.
The apparent stars of the show were the optimal CuHARs effects, decreasing
metabolism of glioma to 76% efficiency at 24 hrs. and 71% at 48 hrs., while leaving the
astrocytes at 82% and 79% respectively (Table 3-2-1/2). The data from the later test of
CuNPs 10µg/ml vs. the CuHARs remaining at 20µg/ml (Table 3-5-3) is somewhat
inconclusive-to slightly supportive of the earlier hypothesis of MOBs having a less harsh
effect on cell health compared to a raw nanoparticle counterpart (Table 3-5-1). Both
compounds had similar effects on the cell’s metabolism, but the mass of copper was
higher in CuHARs and performed better at the 24hrs. mark and worse at the 48hrs. mark.
This could indicate a slower release of copper ions into the environment. The data
collected on CuNPs only served to compound the common understanding of their toxic
effects on cell health.
Speaking to metabolism results where the controls were at 100%, while a material
may be at 130% at 48hrs., a likely conclusion may be made: population control. If, per
say, a culture has to last 5 days at full-function uninhibited, but only has 3 days of
resources, it would not survive. However, if one were to slow the metabolism it may last,
as the cells were not capable of growing at the same rate. If both conditions were
examined at day 4, the delayed reduction in metabolism of cells would appear to have
outperformed the control. In the same sense, the controls may have been reaching a state
of exhaustive resources; not acidic enough or low enough on nutrients to kill but to
diminish growth. Meanwhile, the cells that have just finished processing a material (Fig
3-5-1) are on the up-and-coming.
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5.2 Future Works
Carrying this work forward, I would like to investigate the reactions of a coculture of glioma and astrocyte cells62. The diseased brain is never truly only “healthy” or
diseased. By attempting to model a more holistic view of a typical cancer patient of each
cell type, by plating at a similar cell density as in a patient, we may gain better
understanding of the response of materials in vivo.
Seeing the work that is comparing the CuNPs at varying dosages (3.5), it begs the
question of what concentrations are any of the MOBs/NPS effective; as it may be but a
slight factor needed to turn the tide against glioma. Perhaps even lowering the dosage of a
successful treatment but periodically dosing a co-culture could selectively deplete it of
cancerous cells. X-ray diffraction (XRD) could be used to determine the metal by mass of
each of the compounds.
Next, there were several other MOBs that time did not permit the study of such as
gold, silver and iron. All of which have shown similar promise in regards to internal
medicine and related work6, 7.
Nitric oxide assay63 would be one of the many additional ways I would like to
evaluate cell culture stress. Release of NO by endothelial cells is shown to relax blood
vessels and increase blood flow. By examining the release of this gas64, we may be able
to determine if the cells are signaling inadvertently for more or less oxygen among other
blood delivered resources, which could indicate stress.
Another assay I would like to preform is referred to as Diff-Quik. This assay is
useful for its multicolored staining of cellular components, allowing evaluation of the
nuclear area along with total cell area65.
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Antibodies are an unbound source of potential in the field of cancer therapy66. The
disturbance of the transferrin receptor 1 (TfR1) may be a way to increase uptake of
degraded fragments and ions from these materials67. In conjunction with the CuHARs’
promising data presented here or other MOBs, a deregulated receptor which has control
over iron-based uptake may also be applicable with other metal based materials. With the
addition of transferrin, the antibody that stimulates this receptor, there is a possibility to
increase the potential influx of anti-cancer metal ions and fragments.
Lastly, I would like to culture cells with CuHARs, adding them at similar doses
for both glioma and astrocytes. In contrast to the earlier displayed work provisions would
have to be made for cells intended to grow past the normal 90% confluence of a flask (59 days), this may be the addition of materials to a cell flask that is raised and passaged,
later performing MTT assay on the next “generation” of the cell line. This could also be
replicated by plating at a similar cell density in a larger 25ml flask. There, of course, is
also the interest in DAPI and calcium imaging on these groups. For calcium imaging, I
would expect to see a return to fairly normal response, and with DAPI I suspect for 1-2
cell passage cycles we may see some minor morphology differences indicating stress; but
beyond that not much negative impact.
To compound this previous proposed experiment, I would like to add astrocytes to
a culture first as they are slower growing. Upon a stable population being achieved, add a
fluorescent tracker such as a quantum dot whose fluorescence can sometime be
maintained through cell growth periods. A wash would then be performed days later,
once the astrocytes had incorporated the particles to remove free floating cells. The
culture could then be inoculated with a high dose of similarly labeled glioma, let grow,
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washed for dead cells and tracked. A possible treatment would then show a vast reduction
in the glioma labeled cells compared to the astrocyte labeled cells using these tracking
strategies.

APPENDIX A
ASTROCYTE CULTURE MEDIA
For 250mL total media, use the following amounts:
• 12.5mL Horse serum (5.0%)
• 12.5mL Fetal Bovine Serum (FBS) (0.5%)
• 12.5mL Penicillin/Streptomycin (P/S) (0.5%)
• 223.75Ml Ham’s F-12K media with L-Glutamine (89.5%)
In a sterile environment, add the component together in the following manner:
1. Add 100mL of Ham’s F-12K media to sterile vacuum filtration unit.
2. Add horse serum, FBS, and P/S to vacuum filtration unit.
3. Add 123.5 mL of Ham’s F-12K media to unit.
4. Place cap on unit, carefully turn on vacuum.
5. Allow the liquid to pass through the filter, turn off vacuum before bubbles
form.
6. Once vacuum is off, remove cap and place screw on cap on the container.
7. Label media including name and date made, store in refrigerator.
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APPENDIX B
CRL-2303 CULTURE MEDIA
For 250mL total media, use the following amounts:
• 221.3mL Delbecco Modified Eagle’s Medium (DMEM) (88.52%)
• 25mL Fetal Bovine Serum (FBS) (10.0%)
• 1.25mL Penicillin/Streptomycin (P/S) (0.5%)
• 2.5mL Amino Acid Solution (1.0%)
In a sterile environment, add the component together in the following manner:
1. Add 110.65 mL of DMEM to sterile vacuum filtration unit.
2. Add P/S to vacuum filtration unit.
3. Add 25mL FBS to vacuum filtration unit.
4. Add 2.5mL Amino Acid Solution to vacuum filtration unit.
5. Add 110.65 mL of DMEM to sterile vacuum filtration unit.
6. Place cap on unit, carefully turn on vacuum.
7. Allow the liquid to pass through the filter, turn off vacuum before bubbles
form.
8. Once vacuum is off, remove cap and place screw on cap on the container.
9. Label media including name and date made, store in refrigerator.
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APPENDIX C
POLY-LYSINE PROTOCOL
To coat a dish
1. Use a 1:1 ratio of Poly-lysine to sterile water, or use recycled
2. Use enough mixture to coat the disk/flask and let sit for at least 1 hour at room
temp
3. Withdrawal the mixture and store it for future use if it is first batch labeling
recycled PLL
4. Wash the flask/dish with PBS 1X and you are ready to plate cells
Important information:


When poly lysine is sterile, operations should be carried out in the hood.



The poly-lysine mixture should be stored in a refrigerated environment and
can only be reused a single time. Make sure to label (sterile or NS)
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APPENDIX D
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DAPI STAING PROTOCOL
Obtain Locke’s solution and DAPI aliquots at 14.24 mMol in DI water.
First dilute 3uL of the DAPI stock solution in 297uL of Locke’s. Next using the
intermedia dilution just created preform a 1:10 with the media in the dish you are
staining. For example, if you have 3mL of media in the well of a 12 well plate you will
need to add 300uL. Once DAPI has been add incubate the plate at 37*C for 10 minutes
and check. Healthier cells may take longer to stain as they will resist the intrusion.
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APPENDIX E
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MTT ASSAY FOR ASTOCYTES and CRL-2303
It will take 400uL of solution to completely cover the bottom of a 24-well plate.
This being considered, 9.6 mL of MTT would be needed to treat an entire plate. 11 ml
will be prepared as a safety buffer amount. Similarly, a wash of RPMI is also prepared at
300μL and 7.2mL total 8l safety buffer.
1. Dilute MTT to 5.0mg/ml in RPMI Media the follow a 4x dilution for a final
concentration of 1.25mg/ml. for this 13.75mg of MTT powder needs to be added
to 11ml of warmed (37*C) RPMI Media.
2. Cell culture Media is removed from cells. A wash of 300uL per well is added and
plate gently swirled.
3. Wash solution is removed and 400uL of MTT assay solution is added.
4. Cells are placed back into the incubator at 37* Celsius and incubated at least 1 hr.
5. Cells are removed from incubator and the media is gently removed and discarded
6. 500μL of 91% isopropanol is added to each of the wells and agitated to dissolve
the purple crystals. The liquid is removed and placed into individual cuvettes.
7.

A pre-warmed spectrophotometer is used and set to blank with 500uL of sterile
water. Absorbance is set to 630nm.
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APPENDIX F
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Standard 7.0 ml Synthesis of MOBs
In sterile conditions
1. Create a solution with a ratio of 7.29mg cysteine to 100μl of sterile 1.0 normal
sodium hydroxide.
2. Add 7μL of the created fresh stock cysteine solution to a T25 flask.
3. Add 6,643μL of Sterile water to the flask.
4. Warm in an oven set to 37 °Celsius for 30 minutes.
5. While the flask is warming, prepare a solution of your desired metal such as a
pure nanoparticle like copper or a sulfate like CuSO4 with 2mg/ml in sterile
water.
6. Once the flask has warmed, remove and add 350μl of your metal solution and
place back in the oven to begin synthesis for at least 5 hrs. and up to over
night
7. Remove from oven and place in fridge. Micro MOBs should be visible with
10x microscopy.
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